EUVIMED · CrossrefZeitschrift
Clinical Oncology
ISSN 0936-6555 · Elsevier BV
Neueste Artikel
Interpretable Prediction of Lymphopenia Following Neoadjuvant Chemoradiotherapy for rectal Cancer: An Analysis of the ARISTOTLE randomized phase 3 Trial
Accelerated Partial Breast Irradiation in the Supine vs Prone Position: A Comparison of Dosimetry and Acute Toxicity in a Real World Population
Aseptic Capacity is No Longer Simply a Pharmacy Issue: It is now a Limiting Factor in Cancer Treatment Delivery
Preliminary results of the STARLORD study: a mono-institutional prospective phase II experience of STereotActic Radiotherapy for LOcally advanced non small cell lung cancer ineligible for concurrent chemoRaDiation
Stereotactic Body Radiotherapy for Central and Ultracentral Lung Tumors: A Multicenter Real-world Outcomes Analysis
Drivers of Change in Radiotherapy Practice: Lessons From a UK Tertiary Cancer Centre (2013–2023)
Patient Reported Outcome Measures of Head and Neck Cancer Patients Treated With Curative Intent Radiotherapy Within the Head and Neck 5000 Cohort
Addressing Africa's Radiotherapy Workforce Crisis: Harnessing Artificial Intelligence for Equitable Cancer Care
Spectral CT in Modern Radiotherapy: A Clinical Framework for Precision Treatment Planning, Adaptive Radiotherapy, and Response Assessment
Respiratory Instability–driven Cardiac Dose Deviation in Postmastectomy Deep Inspiration Breath-hold Volumetric Modulated Arc Therapy (DIBH VMAT): Development and External Validation of a Respiratory-informed Predictive Framework
Contralateral Neck Recurrence Rate Following Definitive Unilateral Radiotherapy for Well-lateralised Oropharyngeal Squamous Cell Carcinoma
Global Oncology Index: Mapping Disparities in Cancer Care Across Globe
Comment on “Artificial Intelligence in Health Care: A Rallying Cry for Critical Clinical Research and Ethical Thinking”
UK Photon Radiotherapy Practice for Oligodendroglioma –Data From the Analysis of Proton vs Photon Radiotherapy in Oligodendroglioma and Assessment of Cognitive Health Trial (ISRCTN:1339049) Radiotherapy Quality Assurance (RTQA) Programme
Local Salvage Without Systemic Therapy in Radiorecurrent Prostate Cancer: How Far can HIFU Take Us?
Real-world Experience with Sotorasib in KRAS G12C-Mutated Advanced Non-small Cell Lung Cancer: Clinical Outcomes and Tolerability in the UK
HYPOCON: A Randomised Proof of Concept Clinical Trial of Biphasic Fractionation Schedules to Overcome Hypoxia in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Treated with Curative Intent Primary Chemo-radiotherapy
How Reliable Are Our Clinical Guidelines? The Impact of Retracted Trials in Oncology
Whole-pelvic Versus Prostate-only Radiotherapy in Clinically Node-negative High-Risk Localised Prostate Cancer: A Systematic Review and Meta-analysis with Reconstructed Individual-patient Data
The National Ovarian Cancer Audit (NOCA) 2026 State of the Nation Report: Key Findings, Recommendations, and Quality Improvement Intervention to Improve the Quality of Ovarian Cancer Care in England and Wales
A Multicentre Retrospective Cohort Study of Hypofractionated Radiotherapy in Head and Neck Cancer
Body Composition Changes in Patients with Oropharyngeal Squamous Cell Carcinomas Treated With Radiotherapy
Acute Myocardial Infarction in Head and Neck Cancer Patients and Survivors: A Population-Based Cohort Study of Patient, Disease, and Treatment Factors
Multidisciplinary Tumor Board in Oropharyngeal Cancer: Impact on Treatment Regimen, Treatment Initiation and Survival
Patient-reported Outcomes after Standard and Dose-escalated Prostate Stereotactic Body Radiotherapy
Increasing the use of Radical Radiotherapy is Associated with Improved Lung Cancer Specific Survival–A Regional Population-based Patient-level Study
Final Results From a Phase I Dose Escalation Study (DESTROY-1) in Stereotactic Boost After Prior Radiotherapy
GSTTAutoseg: Leveraging Open-Source Tools to Develop and Deploy Bespoke In-house Autocontouring Solutions for Radiotherapy
Cost-effectiveness of Adjuvant Pembrolizumab in Resected Localized Renal Cell Carcinoma in Sri Lanka: A decision-analytic Markov model
Treatment near the end of life in pancreatic cancer in England
Jahrgänge
2027 · 12026 · 1822025 · 2962024 · 2552023 · 2652022 · 3292021 · 2272020 · 2282019 · 2592018 · 2702017 · 2802016 · 2362015 · 1942014 · 1832013 · 1502012 · 1442011 · 3002010 · 1572009 · 1472008 · 1592007 · 3122006 · 1882005 · 1602004 · 1562003 · 1732002 · 1452001 · 2312000 · 1891999 · 1081998 · 1541997 · 1501996 · 1901995 · 1641994 · 1331993 · 1971992 · 1481991 · 2721990 · 1031989 · 53
EUVIMED